Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

被引:5
|
作者
Miguel Rivera-Caravaca, Jose [1 ]
Marin, Francisco [1 ]
Asuncion Esteve-Pastor, Maria [1 ]
Galvez, Josefa [2 ]
Lip, Gregory Y. H. [3 ,4 ,5 ]
Vicente, Vicente [2 ]
Roldan, Vanessa [2 ]
机构
[1] Univ Murcia, Hosp Clin Univ Virgen de la Arrixaca, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Dept Cardiol,CIBERCV, Murcia, Spain
[2] Univ Murcia, Hosp Gen Univ Morales Meseguer, Inst Murciano Invest Biosanitaria IMIB Arrixaca, Dept Hematol & Clin Oncol, Murcia, Spain
[3] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool, Merseyside, England
[4] Liverpool Heart & Chest Hosp, Liverpool, Merseyside, England
[5] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark
来源
BMJ OPEN | 2019年 / 9卷 / 12期
关键词
CLINICAL CLASSIFICATION SCHEMES; BLEEDING RISK-FACTORS; NATIONAL REGISTRY; PREDICTING STROKE; SCORE; ANTICOAGULATION; STRATIFICATION; HEMORRHAGE; WARFARIN; DEFINITION;
D O I
10.1136/bmjopen-2019-033712
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction Atrial fibrillation (AF) is characterised by a high stroke risk. Vitamin K antagonists (VKAs) are the most commonly used oral anticoagulants (OACs) in Spain, but their efficacy and safety depend on the time in therapeutic range of International Normalized Ratio (INR) 2.0-3.0 over 65%-70%. Unfortunately, the difficulties of maintaining an optimal level of anticoagulation and the complications of VKAs (particularly haemorrhagic ones), frequently lead to cessation of this therapy, which has been associated with higher risk of adverse events (AEs), including ischaemic stroke. Our aims are as follows: (1) to evaluate the quality of oral anticoagulation with VKAs, the prevalence of poor quality of anticoagulation, and to identify factors predisposing to poor quality anticoagulation; and (2) to identify patients who will stop OAC and to investigate what factors influence the decision of OAC withdrawal. Methods and analysis Prospective observational cohort study including outpatients newly diagnosed with AF and naive for OACs from July 2016 to June 2018 in an anticoagulation clinic. Patients with prosthetic heart valves, rheumatic mitral valves or valvular AF will be excluded. Follow-up will extend for up to 3 years. During this period, the INR results and changes in the anticoagulant therapy will be recorded, as well as all AEs, or any other information that would be relevant to the proper conduct of research. Ethics and dissemination All patients were informed about the nature and purpose of the study, and the protocol was approved by the Ethics Committee of Hospital General Universitario Morales Meseguer (reference: EST:20/16). This is an observational study focusing on 'real life' practice and therefore all treatments and follow-up will be performed in accordance to the routine clinical practice with no specific interventions or visits. The results of our study will be disseminated by presentations at national and international meetings, and publications in peer-reviewed journals.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Diagnosis and Treatment of Atrial Fibrillation
    Gutierrez, Cecilia
    Blanchard, Daniel G.
    AMERICAN FAMILY PHYSICIAN, 2016, 94 (06) : 442 - 452
  • [32] Underuse of anticoagulation in patients with atrial fibrillation
    Vallakati, Ajay
    Lewis, William R.
    POSTGRADUATE MEDICINE, 2016, 128 (02) : 191 - 200
  • [33] Contemporary Management of Atrial Fibrillation
    Davis, Leslie L.
    JNP-JOURNAL FOR NURSE PRACTITIONERS, 2013, 9 (10): : 643 - 652
  • [34] Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project
    Banerjee, Amitava
    Taillandier, Sophie
    Olesen, Jonas Bjerring
    Lane, Deirdre A.
    Lallemand, Benedicte
    Lip, Gregory Y. H.
    Fauchier, Laurent
    EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (03) : 295 - 301
  • [35] Bleeding as an Outcome Among Patients With Nonvalvular Atrial Fibrillation in a Large Managed Care Population
    Deitelzweig, Steven B.
    Pinsky, Brett
    Buysman, Erin
    Lacey, Michael
    Makenbaeva, Dinara
    Wiederkehr, Daniel
    Graham, John
    CLINICAL THERAPEUTICS, 2013, 35 (10) : 1536 - 1545
  • [36] Effects of antithrombotic drugs on the prothrombotic state in patients with atrial fibrillation: The west Birmingham atrial fibrillation project
    Voukalis, Christos
    Lip, Gregory Y. H.
    Shantsila, Eduard
    THROMBOSIS RESEARCH, 2021, 200 : 149 - 155
  • [37] Impact of Gender on the Prognosis of Patients With Nonvalvular Atrial Fibrillation
    Inoue, Hiroshi
    Atarashi, Hirotsugu
    Okumura, Ken
    Yamashita, Takeshi
    Origasa, Hideki
    Kumagai, Naoko
    Sakurai, Masayuki
    Kawamura, Yuichiro
    Kubota, Isao
    Matsumoto, Kazuo
    Kaneko, Yoshiaki
    Ogawa, Satoshi
    Aizawa, Yoshifusa
    Chinushi, Masaomi
    Kodama, Itsuo
    Watanabe, Eiichi
    Koretsune, Yukihiro
    Okuyama, Yuji
    Shimizu, Akihiko
    Igawa, Osamu
    Bando, Shigenobu
    Fukatani, Masahiko
    Saikawa, Tetsunori
    Chishaki, Akiko
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 113 (06) : 957 - 962
  • [38] Bleeding in anticoagulated patients with atrial fibrillation: practical considerations
    Undas, Anetta
    Drabik, Leszek
    Potpara, Tatjana
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2020, 130 (01): : 47 - 58
  • [39] Apixaban in Patients with Atrial Fibrillation
    Connolly, Stuart J.
    Eikelboom, John
    Joyner, Campbell
    Diener, Hans-Christoph
    Hart, Robert
    Golitsyn, Sergey
    Flaker, Greg
    Avezum, Alvaro
    Hohnloser, Stefan H.
    Diaz, Rafael
    Talajic, Mario
    Zhu, Jun
    Pais, Prem
    Budaj, Andrzej
    Parkhomenko, Alexander
    Jansky, Petr
    Commerford, Patrick
    Tan, Ru San
    Sim, Kui-Hian
    Lewis, Basil S.
    Van Mieghem, Walter
    Lip, Gregory Y. H.
    Kim, Jae Hyung
    Lanas-Zanetti, Fernando
    Gonzalez-Hermosillo, Antonio
    Dans, Antonio L.
    Munawar, Muhammad
    O'Donnell, Martin
    Lawrence, John
    Lewis, Gayle
    Afzal, Rizwan
    Yusuf, Salim
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (09) : 806 - 817
  • [40] Bleeding in anticoagulated patients with atrial fibrillation: practical considerations
    Undas, Anetta
    Drabik, Leszek
    Potpara, Tatjana
    KARDIOLOGIA POLSKA, 2020, 78 (02) : 105 - 116